Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis
- PMID: 8317461
- DOI: 10.1002/ajh.2830430111
Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis
Abstract
B-cell chronic lymphocytic leukemia (B-CLL) associated with bone marrow fibrosis is described. The conditioned medium of the CLL cells contained a high quantity of interleukin 1 alpha (IL-1 alpha), and showed growth promoting activity for marrow fibroblasts which was partially inhibited by anti IL-1 alpha antibody. In addition, the conditioned medium as well as IL-1 alpha stimulated the growth of marrow fibroblasts from the patient. These results strongly suggested the marrow fibrosis occurred by the secretion of IL-1 alpha from the CLL cells and its growth stimulation of marrow fibroblasts. As far as we know, this is the first case in which B-CLL was associated with marrow fibrosis, and its mechanism was investigated.
Similar articles
-
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.Leuk Lymphoma. 1992 Jun;7(3):195-204. doi: 10.3109/10428199209053623. Leuk Lymphoma. 1992. PMID: 1282428 Clinical Trial.
-
B-CLL in PLL transformation associated with hypercalcemia.Leuk Lymphoma. 1994 Jan;12(3-4):321-5. doi: 10.3109/10428199409059606. Leuk Lymphoma. 1994. PMID: 8167564 Review.
-
CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia.Leuk Lymphoma. 1994 Mar;13(1-2):89-94. doi: 10.3109/10428199409051656. Leuk Lymphoma. 1994. PMID: 7517747
-
[Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].Klin Med (Mosk). 1991 Jan;69(1):94-7. Klin Med (Mosk). 1991. PMID: 2023411 Russian.
-
Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.Int J Clin Exp Pathol. 2015 Apr 1;8(4):4186-203. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097612 Free PMC article. Review.
Cited by
-
Simultaneous presence of two hematological malignancies: chronic lymphocytic leukemia and myelofibrosis in a patient.Indian J Hematol Blood Transfus. 2011 Mar;27(1):33-4. doi: 10.1007/s12288-010-0020-8. Epub 2010 Nov 18. Indian J Hematol Blood Transfus. 2011. PMID: 22379292 Free PMC article.
-
Chronic Lymphocytic Leukemia and Myelofibrosis.Case Rep Hematol. 2018 Aug 8;2018:7426739. doi: 10.1155/2018/7426739. eCollection 2018. Case Rep Hematol. 2018. PMID: 30159182 Free PMC article.
-
Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review.Adv Hematol. 2009;2009:179847. doi: 10.1155/2009/179847. Epub 2009 Nov 25. Adv Hematol. 2009. PMID: 20049166 Free PMC article.
-
Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen.J Biol Chem. 2004 Feb 6;279(6):4820-8. doi: 10.1074/jbc.M310999200. Epub 2003 Nov 14. J Biol Chem. 2004. PMID: 14617627 Free PMC article.
-
Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis.Leuk Res Rep. 2023 Aug 28;20:100390. doi: 10.1016/j.lrr.2023.100390. eCollection 2023. Leuk Res Rep. 2023. PMID: 37680324 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials